68 results on '"Åsberg, Anders"'
Search Results
2. Long-term Kidney Transplant Survival Across the Globe
3. Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation
4. Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
5. Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
6. Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
7. Kidney-transplanted Adolescents—Nonadherence and Graft Outcomes During the Transition Phase: A Nationwide Analysis, 2000–2020
8. Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
9. 213.3: Long-term Outcome and Complications in Pediatric ABO-incompatible Living Donor Kidney Transplantation With rituximab Induction: A Multi-centre Investigation From the Nordic Paediatric Renal Transplantation Study Group
10. 213.4: Single-dose Rituximab Induction May Prevent EBV Viremia in Paediatric Kidney Recipients Long-term: An Investigation From the Nordic Paediatric Renal Transplantatioinn Study Group
11. A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
12. Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
13. Posttransplant Hypertension Matters!
14. Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
15. Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients
16. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
17. Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
18. Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
19. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
20. The Authors’ Reply: Placental Pathology in Pregnancies After Kidney Transplantation
21. Immunosuppression and Reproductive Health After Kidney Transplantation
22. 242.2: Similar 1-year organ function from controlled donation after circulatory death using normo-thermic regional perfusion and donation after brain death.
23. 233.4: The Scandinavian exchange program: Ischemic time for imported kidneys in Norway and factors associated with long ischemic time.
24. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
25. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
26. A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
27. Adherence to Immunosuppressive Medications in Renal Transplant Recipients – Different Tools Capture Different Patients
28. Outcomes of Kidney Transplantation in Former Non Kidney Solid Organ Transplant
29. Determination of Tacrolimus Concentration and Protein Expression of P-glycoprotein in Single Human Renal Core Biopsies
30. A Limited Sampling Strategy to Estimate Whole Blood and Intra-lymphocyte Exposure of Everolimus in Renal Transplant Recipients using Population Pharmacokinetic Modeling and Bayesian Estimators
31. High-Dose Fish Oil Supplementation Increase Tacrolimus Exposure in Stable Renal Transplant Recipients
32. High Tacrolimus Clearance – A Risk Factor for Development of Interstitial Fibrosis and Tubular Atrophy in the Transplanted Kidney
33. First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
34. Preserved Insulin Sensitivity and Kidney Function One Year After Successful Pancreas Transplantation
35. Use of Empagliflozin in Renal Transplant Recipients with Post Transplantation Diabetes Mellitus
36. A Simple Strategy for Diagnosis of PTDM in Stable Kidney Transplanted Patients
37. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies
38. The Authors’ Reply
39. Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
40. How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
41. High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
42. Exposure to Mycophenolate and Fatherhood
43. Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
44. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
45. Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
46. Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
47. Prediction of Fat-Free Mass in Kidney Transplant Recipients
48. Chronic musculoskeletal complaints as a predictor of mortality—The HUNT study
49. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients—A Prospective, Randomized Study
50. Closer to the Site of Action
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.